Search Results - "Ebbo, M."

Refine Results
  1. 1

    Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage? by Michot, J.M., Lazarovici, J., Tieu, A., Champiat, S., Voisin, A.L., Ebbo, M., Godeau, B., Michel, M., Ribrag, V., Lambotte, O.

    Published in European journal of cancer (1990) (01-11-2019)
    “…Immune checkpoint inhibitors (ICIs) are changing the treatments of many patients with cancer. These immunotherapies are generally better tolerated than…”
    Get full text
    Journal Article
  2. 2

    IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria by Schleinitz, N, Briantais, A, Ebbo, M

    Published in La revue de medecine interne (01-12-2020)
    “…The concept of IgG4-related disease (IgG4-RD) has recently been individualized in the early 2000s, but most of the organ involvements are known since more than…”
    Get full text
    Journal Article
  3. 3

    Adult immune thrombocytopenia and thrombopoietin receptor agonist: Ten years later by Ebbo, M, Rivière, E, Godeau, B

    Published in La revue de medecine interne (01-01-2021)
    “…Ten years after their licence in France, the use of the two thrombopoietin receptor agonists (TPO-RA), eltrombopag and romiplostim, has deeply modified the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    IgG4 hypophysitis: Diagnosis and management by Lojou, M., Bonneville, J.F., Ebbo, M., Schleinitz, N., Castinetti, F.

    Published in La Presse médicale (1983) (01-04-2020)
    “…IgG4-related hypophysitis is a rare disease, due to a lymphoplasmocytic IgG4 positive infiltration of the pituitary. Literature data are scarce, even though…”
    Get full text
    Journal Article
  8. 8

    NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia by Ebbo, M, Audonnet, S, Grados, A, Benarous, L, Mahevas, M, Godeau, B, Viallard, J.F, Piperoglou, C, Cognet, C, Farnarier, C, Harlé, J.R, Schleinitz, N, Vély, F

    Published in Clinical immunology (Orlando, Fla.) (01-04-2017)
    “…Abstract Immune thrombocytopenic purpura (ITP) is a disease characterized by antibody-mediated platelet destruction. The T- and B-cell subsets have been…”
    Get full text
    Journal Article
  9. 9

    IVIg increases interleukin‐11 levels, which in turn contribute to increased platelets, VWF and FVIII in mice and humans by Nguyen, A., Repesse, Y., Ebbo, M., Allenbach, Y., Benveniste, O., Vallat, J. M., Magy, L., Deshayes, S., Maigné, G., Boysson, H., Karnam, A., Delignat, S., Lacroix‐Desmazes, S., Bayry, J., Aouba, A.

    Published in Clinical and experimental immunology (01-05-2021)
    “…Summary The mechanisms of action of intravenous immunoglobulins (IVIg) in autoimmune diseases are not fully understood. The fixed duration of efficacy and…”
    Get full text
    Journal Article
  10. 10

    Hospitalization for infection in patients treated for giant cell arteritis: A single-centre retrospective study by Lavrard-Meyer, P, Gomes De Pinho, Q, Daumas, A, Benyamine, A, Ebbo, M, Schleinitz, N, Harlé, J R, Jarrot, P A, Kaplanski, G, Berbis, J, Granel, B

    Published in La revue de medecine interne (01-05-2023)
    “…Infections are associated with morbimortality of patients with giant cell arteritis (GCA). The aim of this work was twofold: the identification of factors…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Gaucher Disease type 1 mimicking immune thrombocytopenia: Role of hyperferritinemia and hypergammaglobulinemia in the initial evaluation of an isolated thrombopenia by Faucher, B, Seguier, J, Swiader, L, Cuquemelle, C, Cerutti, D, Ebbo, M

    Published in La revue de medecine interne (01-10-2019)
    “…Gaucher disease type 1 is a rare genetic disease. It can cause thrombocytopenia. Current guidelines do not support bone marrow examination in front of isolated…”
    Get full text
    Journal Article
  13. 13

    Bilateral adrenal hemorrhage under apixaban in primary antiphospholipid syndrome by Lavoipierre, V, Talbot, M, Soubrier, C, De Sainte Marie, B, Seux, V, Solas, C, Morange, P, Bernit, E, Ebbo, M, Faucher, B, Harlé, J R, Schleinitz, N

    Published in La revue de medecine interne (01-07-2020)
    “…Adrenal hemorrhage is a classical but rare complication of antiphospholipid syndrome, revealing diagnosis in one third of the cases. Anti-vitamin K therapy is…”
    Get full text
    Journal Article
  14. 14

    Expectation of patients and caregivers about patient education for immune thrombocytopenia by Mettler, C, Daguzan, A, Lagouanelle, M-C, Briantais, A, Ducros, P, Laborde, S, Gouiran, S, Schleinitz, N, Faucher, B, Ebbo, M

    Published in La revue de medecine interne (01-01-2021)
    “…Immune thrombocytopenia (ITP) durably affects quality of life in patients. Patient education aims at improving their self-care and psychosocial skills,…”
    Get full text
    Journal Article
  15. 15

    Ocular syphilis, a re-emergent pathology: Series of 12 patients in one Hospital, 2017 by Gutierrez, B, Gayet, S, Bertolino, J, Jean, E, Le Goff, L, Voisin, H, Sampo, M, Meunier, B, Harle, J-R, Ebbo, M, Schleinitz, N, Menard, A, Bernit, E

    Published in La revue de medecine interne (01-03-2020)
    “…Syphilis is a sexually transmitted disease. All organs might be affected, but ocular syphilis only occurs in 0.6 percent of patients. We collected all cases of…”
    Get full text
    Journal Article
  16. 16

    Characteristics of giant cell arteritis patients under and over 75-years-old: A comparative study on 164 patients by Daumas, A, Bichon, A, Rioland, C, Benyamine, A, Berbis, J, Ebbo, M, Jarrot, P-A, Gayet, S, Rossi, P, Schleinitz, N, Harle, J-R, Kaplanski, G, Villani, P, Granel, B

    Published in La revue de medecine interne (01-05-2019)
    “…Giant cell arteritis (GCA) is the most common vasculitis of the elderly. In order to assess the impact of age at diagnosis, we compared the characteristics of…”
    Get full text
    Journal Article
  17. 17

    IgG4-related disease treatment in 2014: Update and literature review by Grados, A, Ebbo, M, Jean, E, Bernit, E, Harlé, J-R, Schleinitz, N

    Published in La revue de medecine interne (01-06-2015)
    “…IgG4-related disease is an inflammatory disorder characterized by a polyclonal lymphoplasmacytic tissue infiltrate, with numerous IgG4+ plasmocytes, evolving…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Long-lasting thrombocytopenia induced by glycoprotein IIb/IIIa inhibitor by Christen, J-R, Soubrier, C, Martinez, E, Roumieu, V, Darmon, O, Scandaliaris, S, Picou, L, Cuisset, T, Grados, A, Bernit, E, Ebbo, M, Harlé, J-R, Schleinitz, N

    Published in La revue de medecine interne (01-11-2017)
    “…Glycoprotein IIb/IIIa inhibitors (anti-GPIIbIIIa) prevent platelet binding to fibrinogen. Transient sometimes-severe thrombocytopenia is a well-known side…”
    Get full text
    Journal Article
  20. 20

    IgG4-related systemic disease: emergence of a new systemic disease? Literature review by Ebbo, M, Grados, A, Daniel, L, Vély, F, Harlé, J-R, Pavic, M, Schleinitz, N

    Published in La revue de medecine interne (01-01-2012)
    “…Hyper-IgG4 syndrome, or IgG4-related systemic disease (IgG4-RSD), has been recently characterized by the association of a focal or diffuse enlargement in one…”
    Get full text
    Journal Article